Cargando…
Loss of m(6)A Methyltransferase METTL5 Promotes Cardiac Hypertrophy Through Epitranscriptomic Control of SUZ12 Expression
Enhancement of protein synthesis from mRNA translation is one of the key steps supporting cardiomyocyte hypertrophy during cardiac remodeling. The methyltransferase-like5 (METTL5), which catalyzes m(6)A modification of 18S rRNA at position A(1832), has been shown to regulate the efficiency of mRNA t...
Autores principales: | Han, Yanchuang, Du, Tailai, Guo, Siyao, Wang, Lu, Dai, Gang, Long, Tianxin, Xu, Ting, Zhuang, Xiaodong, Liu, Chen, Li, Shujuan, Zhang, Dihua, Liao, Xinxue, Dong, Yugang, Lui, Kathy O., Tan, Xu, Lin, Shuibin, Chen, Yili, Huang, Zhan-Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920042/ https://www.ncbi.nlm.nih.gov/pubmed/35295259 http://dx.doi.org/10.3389/fcvm.2022.852775 |
Ejemplares similares
-
METTL3 Inhibitors for Epitranscriptomic Modulation of Cellular Processes
por: Moroz‐Omori, Elena V., et al.
Publicado: (2021) -
Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure
por: Yan, Youchen, et al.
Publicado: (2022) -
Evolution of Methyltransferase-Like (METTL) Proteins in Metazoa: A Complex Gene Family Involved in Epitranscriptomic Regulation and Other Epigenetic Processes
por: Wong, Juliet M, et al.
Publicado: (2021) -
Signaling cascades in the failing heart and emerging therapeutic strategies
por: He, Xin, et al.
Publicado: (2022) -
EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis
por: Lang, Fengchao, et al.
Publicado: (2019)